JP2006514945A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006514945A5 JP2006514945A5 JP2004558793A JP2004558793A JP2006514945A5 JP 2006514945 A5 JP2006514945 A5 JP 2006514945A5 JP 2004558793 A JP2004558793 A JP 2004558793A JP 2004558793 A JP2004558793 A JP 2004558793A JP 2006514945 A5 JP2006514945 A5 JP 2006514945A5
- Authority
- JP
- Japan
- Prior art keywords
- contrast agent
- agent according
- contrast
- antagonist
- halogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0228490.9A GB0228490D0 (en) | 2002-12-06 | 2002-12-06 | Novel imaging compounds |
| PCT/GB2003/005319 WO2004052357A1 (en) | 2002-12-06 | 2003-12-05 | Labeled macrophage scavenger receptor antagonists for imaging cardiovascular diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006514945A JP2006514945A (ja) | 2006-05-18 |
| JP2006514945A5 true JP2006514945A5 (https=) | 2007-02-08 |
Family
ID=9949200
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004558793A Pending JP2006514945A (ja) | 2002-12-06 | 2003-12-05 | 循環器疾患造影用の標識マクロファージスカベンジャー受容体拮抗薬 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20060239915A1 (https=) |
| EP (1) | EP1567141A1 (https=) |
| JP (1) | JP2006514945A (https=) |
| CN (1) | CN1744890A (https=) |
| AU (1) | AU2003292384B2 (https=) |
| CA (1) | CA2508663A1 (https=) |
| GB (1) | GB0228490D0 (https=) |
| NO (1) | NO20052633L (https=) |
| RU (1) | RU2005116983A (https=) |
| WO (1) | WO2004052357A1 (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7886497B2 (en) | 2003-12-02 | 2011-02-15 | Valinge Innovation Ab | Floorboard, system and method for forming a flooring, and a flooring formed thereof |
| GB0428020D0 (en) | 2004-12-22 | 2005-01-26 | Amersham Health As | Stabilisation of radiopharmaceutical precursors |
| WO2006077901A1 (ja) * | 2005-01-20 | 2006-07-27 | Shionogi & Co., Ltd. | Ctgf発現阻害剤 |
| RU2474435C2 (ru) * | 2007-11-07 | 2013-02-10 | Джи-И Хелткер БВ | Стабилизация радиофармацевтических композиций |
| US11725395B2 (en) | 2009-09-04 | 2023-08-15 | Välinge Innovation AB | Resilient floor |
| EP2473687B1 (en) | 2009-09-04 | 2019-04-24 | Välinge Innovation AB | A method of assembling resilient floorboards which are provided with a mechanical locking system |
| PT3115161T (pt) | 2011-08-29 | 2020-02-06 | Ceraloc Innovation Ab | Sistema de encaixe mecânico para painéis de pavimento |
| PT3358101T (pt) | 2013-03-25 | 2020-01-21 | Vaelinge Innovation Ab | Tábuas de piso providas de um sistema de bloqueio mecânico e método para produzir um sistema de bloqueio deste tipo |
| EP3802514B1 (en) * | 2018-06-01 | 2022-08-03 | Promega Corporation | Inhibitors of oplophorus luciferase-derived bioluminescent complexes |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5820873A (en) * | 1994-09-30 | 1998-10-13 | The University Of British Columbia | Polyethylene glycol modified ceramide lipids and liposome uses thereof |
| MXPA02000123A (es) * | 1999-06-24 | 2002-07-02 | Smithkline Beecham Corp | Antagonistas de receptor depurador de macrofago. |
| WO2001098264A1 (en) * | 2000-06-21 | 2001-12-27 | Smithkline Beecham Corporation | Macrophage scavenger receptor antagonists |
| EP1377321A4 (en) * | 2001-02-23 | 2006-01-11 | Bristol Myers Squibb Co | RECOVERY ANTAGONISTS RECEIVING DETECTABLE MACROPHAGE RECEPTORS FOR THE IDENTIFICATION OF ATHEROSCLEROSIS AND VULNERABLE PLAQUE BY IMAGING |
-
2002
- 2002-12-06 GB GBGB0228490.9A patent/GB0228490D0/en not_active Ceased
-
2003
- 2003-12-05 CN CNA2003801095526A patent/CN1744890A/zh active Pending
- 2003-12-05 US US10/537,103 patent/US20060239915A1/en not_active Abandoned
- 2003-12-05 CA CA002508663A patent/CA2508663A1/en not_active Abandoned
- 2003-12-05 RU RU2005116983/15A patent/RU2005116983A/ru not_active Application Discontinuation
- 2003-12-05 EP EP03767961A patent/EP1567141A1/en not_active Withdrawn
- 2003-12-05 WO PCT/GB2003/005319 patent/WO2004052357A1/en not_active Ceased
- 2003-12-05 JP JP2004558793A patent/JP2006514945A/ja active Pending
- 2003-12-05 AU AU2003292384A patent/AU2003292384B2/en not_active Ceased
-
2005
- 2005-06-01 NO NO20052633A patent/NO20052633L/no not_active Application Discontinuation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Xia et al. | Liposome-based probes for molecular imaging: from basic research to the bedside | |
| Gao et al. | 99m Tc-conjugated manganese-based mesoporous silica nanoparticles for SPECT, pH-responsive MRI and anti-cancer drug delivery | |
| Santos et al. | Nanostructured porous silicon in preclinical imaging: moving from bench to bedside | |
| Glaus et al. | In vivo evaluation of 64Cu-labeled magnetic nanoparticles as a dual-modality PET/MR imaging agent | |
| US11672866B2 (en) | Osteotropic nanoparticles for prevention or treatment of bone metastases | |
| Wang et al. | A new optical and nuclear dual-labeled imaging agent targeting interleukin 11 receptor alpha-chain | |
| Sarparanta et al. | 18F-labeled modified porous silicon particles for investigation of drug delivery carrier distribution in vivo with positron emission tomography | |
| JP2006514945A5 (https=) | ||
| Zheng et al. | Quantitative CT imaging of the spatial and temporal distribution of liposomes in a rabbit tumor model | |
| JP2006515859A5 (https=) | ||
| RU2007104096A (ru) | Способ лечения аллергии или вызываемых аллергией поражений дыхательных путей и фармацевтическая композиция | |
| JP2010513441A5 (https=) | ||
| Criscione et al. | Development and application of a multimodal contrast agent for SPECT/CT hybrid imaging | |
| RU2008150310A (ru) | Производные ацетамида 2-арилпиразола[1,5 альфа] пиримидин-3-ила в качестве лигандов для белка-транслокатора(18кда) | |
| Liu et al. | Efficient construction of PET/fluorescence probe based on sarcophagine cage: an opportunity to integrate diagnosis with treatment | |
| US20180022768A1 (en) | Radioactive phospholipid metal chelates for cancer imaging and therapy | |
| JP2005523941A5 (https=) | ||
| Huang et al. | Recent advances in PAMAM dendrimer-based CT contrast agents for molecular imaging and theranostics of cancer | |
| EP1691777A2 (en) | Novel differential imaging method | |
| RU2005116983A (ru) | Меченые антагонисты фагоцитарных рецепторов макрофагов для визуализации сердечно-сосудистых заболеваний | |
| JP2009538894A5 (https=) | ||
| US11052163B2 (en) | Homing agents | |
| Mushtaq et al. | Efficient and site-specific 125I-radioiodination of bioactive molecules using oxidative condensation reaction | |
| CN101151053A (zh) | 杂合无机纳米颗粒、其使用和制备方法 | |
| US11266755B2 (en) | Development and application of tumor diagnostic radioactive probe targeting folic acid receptor |